Hospitalizations on the rise in New York City as new COVID strains spread rapidly
Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading...
Social Impact
Pfizer lifts revenue outlook as Covid jab price rise boosts sales
Pfizer raised its sales forecast for its Covid-19 vaccine by $2bn to $34bn on Tuesday, as higher prices offset a...
New bivalent COVID vaccine not more protective, still recommended
But very few people have gotten the new shot. And some of those who have are still getting breakthrough infections,...
How NYC Is Using Your Toilet Water to Predict COVID, Flu Rates and More
Scientists are finding ways to predict the future community spread of infectious diseases like coronavirus, monkeypox and polio by investigating...
COVID is down, but far from out: It might be time for a booster shot
Should I take the new COVID booster shot?” I was asked this question again this weekend while speaking to a...
New Omicron subvariants BQ.1, BQ.1.1 make gains as BA.5 fades
The rise of new coronavirus subvariants is continuing to erode the grip the Omicron strain BA.5 has held for months,...
Scientists have their eyes on several “Deltacrons”—new COVID variants with the potential to attack the lungs like Delta and spread as easily as Omicron
Earlier this year, all eyes were on “Deltacron”—a frankenvirus, of sorts, that combined Delta and Omicron, and potentially the worst...
Feehery: The COVID election
The first thing that Italy’s new prime minister, Giorgia Meloni, did when she took power there was get rid of...
Workers flee China’s biggest iPhone factory over Covid outbreak
New Delhi CNN Business — Foxconn, one of Apple’s largest suppliers, is wrestling with major disruption at its biggest iPhone...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3EINLPHBEVK5JOJFZ5XEWQVOOQ.jpg "Pfizer boosts COVID vaccine sales forecast by bln to bln")
Pfizer boosts COVID vaccine sales forecast by $2 bln to $34 bln
Nov 1 (Reuters) - Pfizer Inc (PFE.N) on Tuesday raised its forecast for annual sales of its COVID-19 vaccine by...